Tissue Engineering and Transplantation in the Fetus

Principles of Tissue Engineering: Fourth Edition

Volumn , Issue , 2013, Pages 511-529

  Fauza, Dario O ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Amniotic mesenchymal stem cell; Amniotic stem cell; Congenital anomaly; Fetal stem cell; Fetal tissue engineering; Fetal transplantation; Fetus; Neonate; Perinatal; Placental mesenchymal stem cell; Placental stem cell; Umbilical cord blood

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; STEM CELLS; TISSUE; TISSUE ENGINEERING; TRANSPLANTATION (SURGICAL);

CONGENITAL ANOMALY; FETUS; MESENCHYMAL STEM CELL; NEONATE; PERINATAL; UMBILICAL CORD BLOOD;

CELL ENGINEERING;

EID: 84903222018     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-398358-9.00026-4     Document Type: Chapter

References (98)

1. Hurst A.F., Tanner W.E., Osman A.A. Addison's disease with severe anemia treated by suprarenal grafting. Proc R Soc med 1922, 15:19.
2. Fichera G. Implanti omoplastici feto-umani nei cancro e nel diabete. Tumori 1928, 14:434.
3. Thomas E.D., Lochte H.L., Lu W.C., et al. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957, 247:491.
4. Klopper A., Diczfalusy E. Foetus and Placenta 1969, Oxford, UK: Blackwell.
5. Diczfalusy E. Reproductive endocrinology in 1974. First edition. Recent progress in reproductive endocrinology 1974, 833-840. Academic Press, London. P.G. Crosignani, V.E. James (Eds.).
6. Vacanti J.P., Morse M.A., Saltzman W.M., Domb A.J., Perez-Atayde A., Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1988, 23(1 Pt 2):3-9.
7. Cusick R.A., Sano K., Lee H., Pollock J.M., Mooney D., Langer R., Vacanti J.P. Heterotopic fetal rat hepatocyte transplantation on biodegradable polymers. Surg Forum 1995, XLVI:658-61.
8. Fauza D.O., Fishman S.J., Mehegan K., Atala A. Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J Pediatr Surg 1998, 33(1):7-12.
9. Fauza D.O., Fishman S.J., Mehegan K., Atala A. Videofetoscopically assisted fetal tissue engineering: skin replacement. J Pediatr Surg 1998, 33(2):357-361.
10. Bianchi D.W., Johnson K.L., Salem D. Chimerism of the transplanted heart. N Engl J Med 2002, 346(18):1410-1412. author reply -2.
11. Khosrotehrani K., Bianchi D.W. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 2005, 118(Pt 8):1559-1563.
12. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000, 6(11):1282-1286.
13. Fauza D.O., Jennings R.W., Teng Y.D., Snyder E.Y. Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida. Surgery 2008, 144(3):367-373.
14. Pereira M.C., Secco M., Suzuki D.E., Janjoppi L., Rodini C.O., Torres L.B., et al. Contamination of mesenchymal stem-cells with fibroblasts accelerates neurodegeneration in an experimental model of Parkinson's disease. Stem Cell Rev 2011, 7(4):1006-1017. Epub 2011/04/20.
15. Javazon E.H., Merchant A.M., Danzer E., Flake A.W. Reconstitution of hematopoiesis following intrauterine transplantation of stem cells. Methods Mol Med 2005, 105:81-94.
16. Flake A.W. In utero stem cell transplantation. Best Pract Res Clin Obstet Gynaecol 2004, 18(6):941-958.
17. Flake A.W. Stem cell and genetic therapies for the fetus. Semin Pediatr Surg 2003, 12(3):202-208.
18. Merchant A.M., Flake A.W. Surgeons and stem cells: a pragmatic perspective on shifting paradigms. Surgery 2004, 136(5):975-980.
19. Nijagal A., Flake A.W., Mackenzie T.C. In utero hematopoietic cell transplantation for the treatment of congenital anomalies. Clin Perinatol 2012, 39(2):301-310. Epub 2012/06/12.
20. Fauza D.O., Marler J.J., Koka R., Forse R.A., Mayer J.E., Vacanti J.P. Fetal tissue engineering: diaphragmatic replacement. J Pediatr Surg 2001, 36(1):146-151.
21. Fuchs J.R., Terada S., Ochoa E.R., Vacanti J.P., Fauza D.O. Fetal tissue engineering: In utero tracheal augmentation in an ovine model. J Pediatr Surg 2002, 37(7):1000-1006.
22. Fuchs J.R., Hannouche D., Terada S., Vacanti J.P., Fauza D.O. Fetal tracheal augmentation with cartilage engineered from bone marrow-derived mesenchymal progenitor cells. J Pediatr Surg 2003, 38(6):984-987.
23. Fuchs J.R., Terada S., Hannouche D., Ochoa E.R., Vacanti J.P., Fauza D.O. Fetal tissue engineering: chest wall reconstruction. J Pediatr Surg 2003, 38(8):1188-1193.
24. Fuchs J.R., Kaviani A., Oh J.T., LaVan D., Udagawa T., Jennings R.W., et al. Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg 2004, 39(6):834-838. discussion -8.
25. Wu X., Rabkin-Aikawa E., Guleserian K.J., Perry T.E., Masuda Y., Sutherland F.W., et al. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol 2004, 287(2):H480-H487.
26. Fuchs J.R., Hannouche D., Terada S., Zand S., Vacanti J.P., Fauza D.O. Cartilage Engineering from Ovine Umbilical Cord Blood Mesenchymal Progenitor Cells. Stem Cells 2005, 23(7):958-964.
27. Fuchs J.R., Nasseri B.A., Vacanti J.P., Fauza D.O. Postnatal myocardial augmentation with skeletal myoblast-based fetal tissue engineering. Surgery 2006, 140(1):100-107.
28. Kaviani A., Perry T.E., Dzakovic A., Jennings R.W., Ziegler M.M., Fauza D.O. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 2001, 36(11):1662-1665.
29. Kaviani A., Perry T.E., Barnes C.M., Oh J.T., Ziegler M.M., Fishman S.J., et al. The placenta as a cell source in fetal tissue engineering. J Pediatr Surg 2002, 37(7):995-999.
30. Kaviani A., Guleserian K., Perry T.E., Jennings R.W., Ziegler M.M., Fauza D.O. Fetal tissue engineering from amniotic fluid. J Am Coll Surg 2003, 196(4):592-597.
31. Krupnick A.S., Balsara K.R., Kreisel D., Riha M., Gelman A.E., Estives M.S., et al. Fetal liver as a source of autologous progenitor cells for perinatal tissue engineering. Tissue Eng 2004, 10(5-6):723-735.
32. Kunisaki S.M., Fuchs J.R., Kaviani A., Oh J.T., LaVan D.A., Vacanti J.P., et al. Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg 2006, 41(1):34-39. discussion -9.
33. Kunisaki S.M., Freedman D.A., Fauza D.O. Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes. J Pediatr Surg 2006, 41(4):675-682.
34. Kunisaki S.M., Jennings R.W., Fauza D.O. Fetal cartilage engineering from amniotic mesenchymal progenitor cells. Stem Cells Dev 2006, 15(2):245-253.
35. Schmidt D., Mol A., Breymann C., Achermann J., Odermatt B., Gossi M., et al. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation 2006, 114(1 Suppl):I125-I131.
36. Schmidt D., Achermann J., Odermatt B., Breymann C., Mol A., Genoni M., et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007, 116(11 Suppl):I64-I70.
37. Steigman S.A., Ahmed A., Shanti R.M., Tuan R.S., Valim C., Fauza D.O. Sternal repair with bone grafts engineered from amniotic mesenchymal stem cells. J Pediatr Surg 2009, 44(6):1120-1126. discussion 6. Epub 2009/06/16.
38. Turner C.G., Fauza D.O. Fetal tissue engineering. Clin Perinatol 2009, 36(2):473-488. xii. Epub 2009/06/30.
39. Klein J.D., Turner C.G., Ahmed A., Steigman S.A., Zurakowski D., Fauza D.O. Chest wall repair with engineered fetal bone grafts: an efficacy analysis in an autologous leporine model. J Pediatr Surg 2010, 45(6):1354-1360. Epub 2010/07/14.
40. Turner C.G., Klein J.D., Steigman S.A., Armant M., Nicksa G.A., Zurakowski D., et al. Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cells. J Pediatr Surg 2011, 46(1):57-61. Epub 2011/01/18.
41. Weber B., Schoenauer R., Papadopulos F., Modregger P., Peter S., Stampanoni M., et al. Engineering of living autologous human umbilical cord cell-based septal occluder membranes using composite PGA-P4HB matrices. Biomaterials 2011, 32(36):9630-9641. Epub 2011/10/08.
42. Weber B., Zeisberger S.M., Hoerstrup S.P. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth. Placenta 2011, 32(Suppl. 4):S316-S319. Epub 2011/05/18.
43. Gray F.L., Turner C.G., Ahmed A., Calvert C.E., Zurakowski D., Fauza D.O. Prenatal tracheal reconstruction with a hybrid amniotic mesenchymal stem cells-engineered construct derived from decellularized airway. J Pediatr Surg 2012, 47(6):1072-1079. Epub 2012/06/19.
44. Turner C.G.B., Pennington E.C., Klein J.D., Wang J., Thakor D., Benedict D., Ahmed A., Teng Y.D., Fauza D.O. The Amniotic Fluid as a Source of Neural Stem Cells in the Setting of Experimental Neural Tube Defects. Stem Cells Dev 2013, 22:548-553.
45. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 2004, 18(6):877-891.
46. Turner C.G.B., Pennington E.C., Klein J.D., Wang J., Thakor D., Benedict D., Ahmed A., Teng Y.D., Fauza D.O. The Amniotic Fluid as a Source of Neural Stem Cells in the Setting of Experimental Neural Tube Defects. Stem Cells Dev 2013, 22:548-553.
47. Milunsky A. Amniotic fluid cell culture. First edition. Genetic disorders and the fetus 1979, 75-84. Plenum Press, New York. A. Milunsky (Ed.).
48. Hoehn H., Salk D. Morphological and biochemical heterogeneity of amniotic fluid cells in culture. Methods Cell Biol 1982, 26:11-34.
49. Gosden C.M. Amniotic fluid cell types and culture. Br Med Bull 1983, 39(4):348-354.
50. Prusa A.R., Marton E., Rosner M., Freilinger A., Bernaschek G., Hengstschlager M. Stem cell marker expression in human trisomy 21 amniotic fluid cells and trophoblasts. J Neural Transm Suppl 2003, 67:235-242.
51. Bili C., Divane A., Apessos A., Konstantinos T., Apostolos A., Ioannis B., et al. Prenatal diagnosis of common aneuploidies using quantitative fluorescent PCR. Prenat Diagn 2002, 22(5):360-365.
52. Torricelli F., Brizzi L., Bernabei P.A., Gheri G., Di Lollo S., Nutini L., et al. Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation. Ital J Anat Embryol 1993, 98(2):119-126.
53. Streubel B., Martucci-Ivessa G., Fleck T., Bittner R.E. [In vitro transformation of amniotic cells to muscle cells - background and outlook]. Wien Med Wochenschr 1996, 146(9-10):216-217.
54. Macek M., Hurych J., Rezacova D. Collagen synthesis in long-term amniotic fluid cell cultures. Nature 1973, 243:289-290.
55. Hurych J., Macek M., Beniac F., Rezacova D. Biochemical characteristics of collagen produced by long term cultivated amniotic fluid cells. Hum Genet 1976, 31(3):335-340.
56. Kaviani A., Jennings R.W., Fauza D.O. Amniotic fluid-derived fetal mesenchymal cells differentiate into myogenic precursors in vitro. J Am Coll Surg 2002, 195(Suppl):S29. [abstract].
57. In 't Anker P.S., Noort W.A., Scherjon S.A., Kleijburg-van der Keur C., Kruisselbrink A.B., van Bezooijen R.L., et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003, 88(8):845-852.
58. In 't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., Noort W.A., Claas F.H., Willemze R., et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003, 102(4):1548-1549.
59. Tsai M.S., Lee J.L., Chang Y.J., Hwang S.M. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004, 19(6):1450-1456.
60. Tsai M.S., Hwang S.M., Chen K.D., Lee Y.S., Hsu L.W., Chang Y.J., et al. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007, 25(10):2511-2523.
61. Prusa A.R., Hengstschlager M. Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit 2002, 8(11):RA253-RA257.
62. Prusa A.R., Marton E., Rosner M., Bernaschek G., Hengstschlager M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?. Hum Reprod 2003, 18(7):1489-1493.
63. Tsai M.S., Hwang S.M., Tsai Y.L., Cheng F.C., Lee J.L., Chang Y.J. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006, 74(3):545-551.
64. De Coppi P., Bartsch G., Siddiqui M.M., Xu T., Santos C.C., Perin L., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007, 25(1):100-106.
65. Klein J.D., Fauza D.O. Amniotic and placental mesenchymal stem cell isolation and culture. Methods Mol Biol 2011, 698:75-88. Epub 2011/03/25.
66. Kunisaki S.M., Fuchs J.R., Steigman S.A., Fauza D.O. A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. Tissue Eng 2007, 13(11):2633-2644.
67. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
68. Noort W.A., Kruisselbrink A.B., in't Anker P.S., Kruger M., van Bezooijen R.L., de Paus R.A., et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002, 30(8):870-878.
69. Zhao P., Ise H., Hongo M., Ota M., Konishi I., Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005, 79(5):528-535.
70. Ochsenbein-Kolble N., Bilic G., Hall H., Huch R., Zimmermann R. Inducing proliferation of human amnion epithelial and mesenchymal cells for prospective engineering of membrane repair. J Perinat Med 2003, 31(4):287-294.
71. Kaviani A., Young A., Fuchs J.R., Jennings R.W., Oh J.T., Fauza D.O. Reduced immunogenicity of mesenchymal amniocytes during expansion in vitro: implications for heterologous tissue engineering applications. J Am Coll Surg 2002, 195(Suppl):S40. [abstract].
72. Moorefield E.C., McKee E.E., Solchaga L., Orlando G., Yoo J.J., Walker S., et al. Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response. PLoS ONE 2011, 6(10):e26535. Epub 2011/11/03.
73. Stable expression of alloantigens during rapid expansion of human amniotic mesenchymal stem cells in vitro: implications for heterologous cell-based therapies 2008, 60th Annual Meeting of the Section on Surgery of the American Academy of Pediatrics, Boston, MA. S.A. Steigman, A. Ahmed, M. Armant, V. de Meijer, L. Bayer-Zwirello, C. Valim (Eds.).
74. Sekhon H.S., Larson J.E. In utero gene transfer into the pulmonary epithelium. Nat Med 1995, 1(11):1201-1203.
75. Garrett D.J., Larson J.E., Dunn D., Marrero L., Cohen J.C. In utero recombinant adeno-associated virus gene transfer in mice, rats, and primates. BMC Biotechnol 2003, 3(1):16.
76. Klein J.D., Turner C.G., Steigman S.A., Ahmed A., Zurakowski D., Eriksson E., et al. Amniotic mesenchymal stem cells enhance normal fetal wound healing. Stem Cells Dev 2011, 20(6):969-976. Epub 2010/10/29.
77. Kunisaki S.M., Armant M., Kao G.S., Stevenson K., Kim H., Fauza D.O. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg 2007, 42(6):974-979. discussion 9-80.
78. Steigman S.A., Armant M., Bayer-Zwirello L., Kao G.S., Silberstein L., Ritz J., et al. Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol. J Pediatr Surg 2008, 43(6):1164-1169.
79. Martin F.H., Suggs S.V., Langley K.E., Lu H.S., Ting J., Okino K.H., et al. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 1990, 63(1):203-211.
80. Takeda J., Seino S., Bell G.I. Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 1992, 20:4613-4620.
81. Shamblott M.J., Axelman J., Littlefield J.W., Blumenthal P.D., Huggins G.R., Cui Y., et al. Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci USA 2001, 98:113-118.
82. Ryan J.M., Pettit A.R., Guillot P.V., Chan J.K., Fisk N.M. Unravelling the Pluripotency Paradox in Fetal and Placental Mesenchymal Stem Cells: Oct-4 Expression and the Case of the Emperor's New Clothes. Stem Cell Rev 2012, (in press). Epub 2011/12/14.
83. Cross J.C., Baczyk D., Dobric N., Hemberger M., Hughes M., Simmons D.G., et al. Genes, development and evolution of the placenta. Placenta 2003, 24(2-3):123-130.
84. Zhang X., Mitsuru A., Igura K., Takahashi K., Ichinose S., Yamaguchi S., et al. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun 2006, 340(3):944-952.
85. Portmann-Lanz C.B., Schoeberlein A., Huber A., Sager R., Malek A., Holzgreve W., et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 2006, 194(3):664-673.
86. Lillie F.R. The theory of the free-martin. Science 1916, 43:611-613.
87. Owen R.D. Immunogenic consequences of vascular anastomosis between bovine twins. Science 1945, 102:400-401.
88. Benito A.I., Diaz M.A., Gonzalez-Vicent M., Sevilla J., Madero L. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 2004, 33(7):675-690.
89. Rocha V., Garnier F., Ionescu I., Gluckman E. Hematopoietic stem-cell transplantation using umbilical-cord blood cells. Rev Invest Clin 2005, 57(2):314-323.
90. Mjosberg J.M., Trifari S., Crellin N.K., Peters C.P., van Drunen C.M., Piet B., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011, 12(11):1055-1062. Epub 2011/09/13.
91. Lucarelli G., Izzi T., Porcellini A., Delfini C. Infusion of fetal liver cells in aplastic anemia. Hamatol Bluttransfus 1979, 24:167-170.
92. Tisato V., Naresh K., Girdlestone J., Navarrete C., Dazzi F. Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK 2007, 21(9):1992-1999. Epub 2007/07/13.
93. Amos T.A., Gordon M.Y. Sources of human hematopoietic stem cells for transplantation - a review. Cell Transplant 1995, 4(6):547-569.
94. Nijagal A., Wegorzewska M., Jarvis E., Le T., Tang Q., MacKenzie T.C. Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice. J Clin Invest 2011, 121(2):582-592. Epub 2011/01/20.
95. Nijagal A., Wegorzewska M., Le T., Tang Q., Mackenzie T.C. The maternal immune response inhibits the success of in utero hematopoietic cell transplantation. Chimerism 2011, 2(2):55-57. Epub 2011/09/14.
96. Moustafa M.E., Srivastava A.S., Nedelcu E., Donahue J., Gueorguieva I., Shenouda S.S., et al. Chimerism and tolerance post-in utero transplantation with embryonic stem cells. Transplantation 2004, 78(9):1274-1282.
97. Lee P.W., Cina R.A., Randolph M.A., Goodrich J., Rowland H., Arellano R., et al. Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs. Exp Hematol 2005, 33(3):371-379.
98. Ashizuka S., Peranteau W.H., Hayashi S., Flake A.W. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation. Exp Hematol 2006, 34(3):359-368.